Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Josep Darbà & Meritxell Ascanio. (2023) Incidence and medical costs of chronic obstructive respiratory disease in Spanish hospitals: a retrospective database analysis. Journal of Medical Economics 26:1, pages 335-341.
Read now
Read now
María Merino, Teresa Martín Lorenzo, Paulina Maravilla-Herrera, Julio Ancochea, José Tomás Gómez Sáenz, Nicole Hass, Jesús Molina, Germán Peces-Barba, Marta Trapero-Bertran, Juan Antonio Trigueros Carrero & Álvaro Hidalgo-Vega. (2022) A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1431-1442.
Read now
Read now
Bernardino Alcázar-Navarrete, Francisco García-Rio, Guadalupe Sánchez, Esther Mariscal, Andrea García, Maribel Cuesta, Estefany Uría & Marc Miravitlles. (2021) Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2149-2161.
Read now
Read now
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Read now
Marc Miravitlles, Alicia Marín, Alicia Huerta, David Carcedo, Alba Villacampa & Jaume Puig-Junoy. (2020) Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1643-1654.
Read now
Read now
Melanie Schroeder, Nicole Benjamin, Laura Atienza, Chandroday Biswas, Alan Martin, John D Whalen, José Luis Izquierdo Alonso, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Alicia Huerta & Afisi S Ismaila. (2020) Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1621-1632.
Read now
Read now
Articles from other publishers (4)
Pasquale Ambrosino, Salvatore Fuschillo, Mariasofia Accardo, Marco Mosella, Antonio Molino, Giorgio Alfredo Spedicato, Andrea Motta & Mauro Maniscalco. (2022) Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications. Journal of Personalized Medicine 12:11, pages 1906.
Crossref
Crossref
Celia Gutiérrez Villegas, María Paz-Zulueta, Manuel Herrero-Montes, Paula Parás-Bravo & María Madrazo Pérez. (2021) Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Economics Review 11:1.
Crossref
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Crossref
María Merino, Renata Villoro, Álvaro Hidalgo-Vega & Concepción Carmona. (2019) Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref